BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5686572)

  • 21. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier.
    Nischwitz V; Berthele A; Michalke B
    Anal Chim Acta; 2008 Oct; 627(2):258-69. PubMed ID: 18809082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Estimation of capillary permeability by means of albumin 131 I in normal state and in edema].
    Macheret H
    Schweiz Med Wochenschr; 1973 Jun; 103(26):934-41. PubMed ID: 4716912
    [No Abstract]   [Full Text] [Related]  

  • 23. [Quantitative analysis of gamma-aminobutyric acid and glutamic acid in the cerebrospinal fluid of schizophrenics].
    Shen QJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 May; 15(2):98-103. PubMed ID: 6127192
    [No Abstract]   [Full Text] [Related]  

  • 24. [Capillary resistance and its significance during physical therapy].
    Bachledová E; Niepel G
    Fysiatr Revmatol Vestn; 1975 Feb; 53(1):36-42. PubMed ID: 1168616
    [No Abstract]   [Full Text] [Related]  

  • 25. Permeability of the blood cerebrospinal fluid barrier during acute immune complex disease.
    Hoffman SA; Arbogast DN; Day TT; Shucard DW; Harbeck RJ
    J Immunol; 1983 Apr; 130(4):1695-8. PubMed ID: 6220064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Disorder of the blood-brain barrier in schizophrenia].
    Kornhuber J; Bauer K
    Dtsch Med Wochenschr; 1986 Jun; 111(26):1041. PubMed ID: 3720557
    [No Abstract]   [Full Text] [Related]  

  • 27. Permeability of the blood-brain barrier in psychiatric patients.
    Torrey EF; Albrecht P; Behr DE
    Am J Psychiatry; 1985 May; 142(5):657-8. PubMed ID: 3985208
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vascular permeability in glaucoma patients suffering from cardiovascular and endocrine diseases].
    Denisiuk NB
    Vrach Delo; 1979 Jun; (6):30-3. PubMed ID: 473716
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoimmune model of schizophrenia with special reference to antibrain antibodies.
    Pandey RS; Gupta AK; Chaturvedi UC
    Biol Psychiatry; 1981 Dec; 16(12):1123-36. PubMed ID: 6186298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pinoline, a beta-carboline derivative in the serum and cerebrospinal fluid of patients with schizophrenia.
    Rimón R; Airaksinen MM; Kari I; Gynther J; Venäläinen E; Heikkilä L; Ryyppö J; Palo J
    Ann Clin Res; 1984; 16(3):171-5. PubMed ID: 6476781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of radionuclids in the study of blood-cerebrospinal fluid dynamics. Modifications induced by administration of hyperpyretogenic and vasodilator substances].
    Nicoletti F; Grasso AM; Gasso G
    Acta Neurol (Napoli); 1965; 20(3):322-41. PubMed ID: 5825948
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of the action of cardiotrast and triiotrast on the permeability of the hematoencephalic barrier for labelled albumin].
    Dorofeev LI
    Farmakol Toksikol; 1968; 31(1):113-4. PubMed ID: 5675336
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hyperbaric oxygenation therapy of acute brain injury and brain edema experimental and clinical study].
    Mogami H; Sugimoto T; Mukawa J; Ikeda T; Koshino K
    No To Shinkei; 1969 Mar; 21(3):261-8. PubMed ID: 5819331
    [No Abstract]   [Full Text] [Related]  

  • 35. Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia.
    Müller N; Riedel M; Hadjamu M; Schwarz MJ; Ackenheil M; Gruber R
    Am J Psychiatry; 1999 Apr; 156(4):634-6. PubMed ID: 10200747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The blood-brain barrier and blood-cerebral spinal fluid barrier.
    Moody DM
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):128-31. PubMed ID: 16959739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy.
    Kumar A; Mittal R; Khanna HD; Basu S
    Pediatrics; 2008 Sep; 122(3):e722-7. PubMed ID: 18725389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical features of patients with the paranoid form of schizophrenia with brain antibodies and brain antigens in their serum and cerebrospinal fluid].
    Savina IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(1):92-7. PubMed ID: 5771498
    [No Abstract]   [Full Text] [Related]  

  • 39. Cerebrospinal fluid tryptophan and brain atrophy in patients with chronic schizophrenia.
    Rimón R; Latvala M; Hyyppä M; Kampman R
    Ann Clin Res; 1982 Jun; 14(3):133-6. PubMed ID: 7137883
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dynamics of intragastric elimination of RISA in the evolutive phases of gastric ulcer].
    Cotul S; Cosma V; Fodor O
    Stud Cercet Med Interna; 1969; 10(3):229-31. PubMed ID: 5345222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.